Trattamenti psicofarmacologici e disfunzioni sessuali

Sexual dysfunction related to psychotropic drugs.
References (updated to 11/04/2011)

Disfunzioni sessuali da psicofarmaci.
Bibliografia (aggiornata al 11/04/2011)

Author:Antonio La Torre, M.D., psychiatrist.
Correspondence: U.O. di Psichiatria, Ospedale di Rovereto, Rovereto (Tn), Italy.
E-mail: 1. Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A: Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapina.
J Clin Psychiatry, 62, 7, 541-544, 2001 2. Aizenberg D, Sigler M, Zemishlany Z, Weizman A: Lithium and male sexual function in affective patients. Clin. Neuropharmacol., 19, 515–519, 1996 3. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A: Sexual dysfunction in male schizophrenic patients.
J Clin Psychiatry, 56, (4), 137-41, 1995 Schizophrenia and sexuality: a review and a report of twelve unusual cases, part I. J Clin Psych, 41, 134–142, 1980 Schizophrenia and sexuality: a review and a report of twelve unusual cases, part II. J Clin Psych, 41, 166–174, 1980 Pharmacological treatment of rapid ejaculation.
Psychiatr Clin North Am, 18, 1, 85-94, 1995 7. Althof SE, Levine SB, Corty EW, Risen CB, Stern EB, Kurit DM: A double-bind crossover trial of clomipramine for rapid ejaculation in 15 couples.
J Clin Psychiatry, 56, 9, 402-407, 1995 8. Althof SE, Resnick K, Levine S, Seftel AD, Stern E, Rosenblatt E, Risen C: Early experience with clomipramine for rapid ejaculation.
J Urol, 153, 4, 474A, 1995 Practise guidelines for the treatment of patients with schizophrenia.
Second edition. April 2004 Impiego del citalopram nell'eiaculazione precoceGiorn. Italiano di Andrologia, 4, 1, 36-39, 1997 Sexual problems in healthy and depressed persons. Int. Clin. Psychopharmacol., 13, (suppl. 6), S1–S4, 1998 Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopramJ Sex Marital Ther, 31, 257-262, 2005 14. Assalian P, Fraser R, Tempier R, Cohen D: Sexuality and quality of life of patients with schizophrenia.
Int J Psychiatr Clin Pract., 4, 29-33, 2000 A new atypicol antipsychotic: quetiapine-induced sexual dysfunctions.
Int J Imp Res., 17, 201-203, 2005 16. Atmaca M, Kuolglu M, Tezcan E, Semercioz A: The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study.
Int J Impot Res, 14, (6), 502-505, 2002 Sexual dysfunction in schizophrenia : focus on recent evidence.
Hum Psychopharmacol., 23, 201-209, 2008 Depression and sexual dysfunction.
Br Med Bull., 57, 81-99, 2001 Sexual dysfunction associated with antidepressant drugsExpert Opin Drug Saf., 3 (5), 457-70, 2004 Sexual side-effects of antidepressant and antipsychotic drug.
Advances in Psychiatric Treatment, 9, 202-210, 2003 SSRI-Associated Sexual Dysfunction Am J Psychiatry , 163, 1504-1509, 2006 Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: toward rethinking DSM criteria of sexual dysfunctions.
Am J Psychiatry, 164, 2, 198-200, 2007 Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants.
J Sex Marital Ther, 34, (4), 353-65, 2008 24. Balon R, Yeragani VK, Pohl R, Rasmesh C: Sexual dysfunction during antidepressant treatment.
J Clin Psychiatry, 54, 209-212, 1993 25. Bandelow B, Chouinard G, Bobes J, Ahokas A, Eggens I, Liu S, : Extended erelease quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharm (CINP), 13, 3, 305–320, 2009 26. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Report of The International Consensus Development Conference On Female Sexual Dysfunction: Definitions and Classifications. 27. Behnke K, Sogaard J, Martin S, Bäuml J, Ravindran AV, Ågren H, Vester-Blokland ED: Mirtazepine orally disintegrating tablet versus sertraline: a prospective onset of action study. J Clin Psychopharmacol., 23, 4, 358-364, 2003 28. Ben Zion IZ, Tessler R, Cohen L, Lerer E, Raz Y, Bachner-Melman R, Gritsenko I, Nemanov L, Zohar AH, Belmaker RH, Benjamin J, Ebstein RP: Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function.
Molecular Psychiatry, 11, 782–786, 2006 Involuntary sperm emission with fluoxetine.
Can J Psychiatry, 40, 7, 431, 1995 Management of sexual dysfunction due to antipsychotics drug therapy.
Cochrane Database Syst Rev, 24, (1), CD003546, 2007 31. Biri H, Isen K, Sinik Z, Onaran M, Kupeli B, Bozkirli I: Sertraline in the treatment of premature ejaculation : a double-blind placebo controlled study.
Int Urol Nephrol, 30, 5, 611-615, 1998 32. Bishop JR, Ellingrod VL, Akroush M, Moline J: The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives.
Hum. Psychopharmacol Clin Exp., 24: 207–215, 2009 33. Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH: Serotonin 2A-1438 G/A and G-Protein Beta 3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side effects.
Neuropsychopharmacology, 31, 2281-2288, 2006 Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients.
Int Clin Psychopharmacol., 20, 19-21, 2005 35. Bobes J, Garcia-Portilla MP, Rejas J Hernandez G, Garcia-Garcia M, Rico-Villademoros F, Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE Study.
J Sex Marital Ther., 29, (2), 125-147, 2003 36. Bonierbale, M., Lançon, C. & Tignol, J.: The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr. Med. Res. Opin. 19, 114–124, 2003 37. Breier A.F., Malhotra AK, Su T-P, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Am J Psychiatry, 156, 294-298, 1999 38. Brugnoli R, Novick D, Belger M, Brown J, Germani S, Donda P, Rossi A, Pancheri P: Effectiveness of antipsychotic treatment for schizophrenia: Italian results of the pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study after 12 months.
Giorn Ital Psicopat., 12, 283-292, 2006 39. Boyarsky BK, Haque W, Rouleau MR, Hirschfeld RM: Sexual functioning in depressed outpatients taking mirtazapine.
Depress Anxiety, 9, (4), 175-9, 1999 The management of medication-induced sexual dysfunctionEssential Psychopharmacology, 3, (2), 39-58, 2000 41. Byerly MJ, Lescouflair E, Weber MT, Bugno RM, Fisher R, Carmody T, Varghese F, Rush An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.
42. Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ: Sexual dysfunction associated with secon-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Schizophr Res., 86, (1-3), 244-250, 2006 43. Calandra C, Terranova F, Loiacono P, Caudullo V, Russo RG, Luca M, Cafiso M: Bupropione nel trattamento del disturbo depressivo maggiore: confronto con paroxetinaGiorn. Ital Psicopat., 16, 128-133, 2010 44. Casey DE, Carson WH, Saha AR, Liebeskind A, Ali MW, Jody D, Ingenitoon GG: Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.
Psychopharmacol., 166, 391-399, 2003 45. Chrzanowski WK, Marcus RN, Torbeyns A, Nylas M, McQuade RD: Effectiveness of long-term aripripazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.
Psychopharmacol., 189, 259-266, 2006 46. Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG: Bupropion extended release compared with escitalopram : effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
J Clin Psychiatry , 67, (5), 736-746, 2006 Burden of phase-specific sexual dysfunction with SSRIs.
J Affect Disord, 91, 27-32, 2006 48. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wolreich M: Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
J Sex Med, 4, (1), 917-29, 2007 49. Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.
J Clin Psychiatry , 62, (3), 185-90, 2001 The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.
Psychopharmacol. Bull. 33, 731–745, 1997 51. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass Prevalence of sexual dysfunction among newer antidepressants.
52. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.
Int Clin Psychopharmacol., 18, (3), 151-6, 2003 53. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL : A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.
J Clin Psychiatry , 65, (1), 62-7, 2004 Depressione e sessualitàHippocrates Edizioni Medico-Scientifiche, Milano, 2001 55. Cohen S, Kühn K-U, Bender S, Erfurth A, Gastpar M., Murafi A, Rothermundt M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Westheide J, Huber TJ: Sexual impairment in psychiatric inpatients: focus on depression.
Pharmacopsychiatry, 40, 2, 58-63, 2007 56. Coleman C, King B, Bolden-Watson C, Bolden- Watson C, Book M J, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A: A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Therapeutics, 23, 7, 1040-1058 , 2001 Priapism associated with conventional and atypical antipsychotic medications: a review.
J Clin Psychiatry, 62, (5), 362-366, 2001 Sexual side effects associated with conventional and atypical antipsychotics.
Psychopharmacol Bull., 35, 3, 89-108, 2001 Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Psychopharmacol Bull., 36, 1, 143-164 , 2002 Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
Isr J Psychiatry Relat Sci., 42, 1, 51-60, 2005 A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Am J Psych, 158, 765–774, 2001 62. Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, Rastrelli G, Sforza A, Faravelli C, Forti G, Maggi M: Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction.
J Sex Med, 6, 5, 1259-69, 2009 63. Costa AM, de Lima MS, Faria M, Filho SR, de Oliveira IR, de Jesus Mari J: A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. J Psychopharmacol, 21, 165–170, 2007 A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophreniaSao Paulo Med J, 124, (5) 291-7, 2006 Pharmacologic modification of psychosexual dysfunction.
J Sex Marital Ther., 13, 239-252, 1987 66. Croft H, Settle E, Houser T, Batey SR, Donahue RMJ, Ascher JA: A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
Clinical Therapeutics, 21, 4, 643-658, 1999 Sexual dysfunction and antipsychotics treatment.
Psychoneuroendocrinology, 28, suppl. 1, 69-82, 2003 68. Cutler AJ, Montgomery SA, Feifel D, Lazarus A, Astrom M, Brecher M: Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. J Clin Psych, 70, 526–539, 2009 69. David SR, Taylor CC, Kinon BJ, Breier A : The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
Clin Ther, 22, 9, 1085-96, 2000 Sexual dysfunction and antidepressant.
Depression, 2, 233-240, 1995 Sexual dysfunction in women using major tranquilizersPsychosomatics, 23, 9, 959-961, 1982 72. Delgado PL, Brannan SK, Mallinckrodt CH, Tran PH, McNamara RK, Wang F, Watkin JG, Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder The DSFI: A Multidimensional Measure of Sexual Functioning. J Sex Marital Ther, 5, 244-281, 1979 Sexual dysfunction in schizophrenics patients, the role of antipsychotics.
Presse Med, 34, (7), 529-32, 2005 Potential side effects of clozapine on the sexual function of schizophrenic man.
J Sex Educ Ther., 26, 4, 334-339, 2001 Comparative safety and tolerability of selective serotonin reuptake inhibitors.
Human Psychopharmacology , 10, (suppl.3), 185-193, 1995 Preliminary results from a multi-center trial of clomipramine in obsessive-compulsive disorder.
Psychopharm Bull, 25, 36-40, 1989 Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs Neurology, 65, (7), 980 – 981, 2005.
Spotlight on bupropion in major depressive disorder. CNS Drugs.;22:613-617, 2 Bupropion. A Review of its use in the management of major depressive disorder.
Drugs, 68, 5, 653-689, 2008 Neuroleptic-induced hyperprolactinemia.
Schizophr Res., 35, S75-S86, 1999 Bupropion improves sexual functioning in depressed minority women: an open-label switch study.
J Clin Psychopharmacol. 2006;26:21Y26.
83. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T: Effects of atypical and typical antypsichotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatients Health Outcomes (IC-SOHO) study.
Eur Psychiatry, 21, 4, 251-258, 2006 84. Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. IC-SOHO Study Group.
J Clin Psych, 65, 3, 312–321, 2004 85. Dossenbach M, Hodge A, Anders M, Molnàr B, Peciukaitiene D, Krupka-Matuszczyk I, Tatu M, Bondar V, Pecenak J, Gorjanc T, McBride M: Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation.
Int. J Neuropsychopharmacol., 8, 195-201, 2005 Treatment of psychotropic-induced hyperprolactinaemia.
Psychiatric Bull, 19, 755-757, 1995 Systematic review of sexual problems : epidemiology and methodology.
J Sex Marital Ther, 28, 399-422, 2002 88. Eberhard J, Lindström E, Holstad M, Levander S: Prolactin level durin 5 years of risperidone treatment in patients with psychotic disorders,Acta Psychiatr Scand., 115, 268-276, 2007 89. Fan X, Henderson DC, Chiang E, Briggs LBN, Freudenrich O, Evins AE, Cather C, Goff Sexual functioning, psychopatology and quality of life in patients with schizophrenia.
Schizophr Res, 94, 119-127, 2007 Sexual functioning and SSRIs.
J Clin Psychiatry, 63, (suppl. 5), 13-16, 2002 91. Feiger A., Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS: Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
J Clin Psychiatry, 57, (Suppl. 2), 53-62, 1996 The effects of antidepressants on sexual functioning in depressed patients: a review.
J Clin Psychiatry, 62, (suppl. 3), 22-34, 2001 93. Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
J Clin Psychiatry, 62, (1), 24-9, 2001 Fluoxetine for premature ejaculation.
95. Fortier P, Mottard JP, Trudel G, Even S: Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. Schizophr Bull, 29, 3, 559–572, 2003 Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety, 1, 233–236, 1994 97. Fujii A, Yasui-Furukori N, Sugawara N, Sato Y, Nakagami T, Saito M, Kaneko S : Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Progress in Neuropsychopharm Biol Psychiatry, 34, 2, 288–293, 2010 Bupropion: an antidepressant without sexual pathophysiological action.
J Clin Psychopharmacol., 5, (1), 24-9, 1985 Increased libido in women receiving trazodone.
Am J Psychiatry, 143, 781-782, 1986 Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P:Mirtazapine substitution in SSRI-induced sexual dysfunction.
J Clin Psychiatry, 61, 5, 356-69, 2000 Ghadirian AM, Annable L, Bélanger MC:Lithium, benzodiazepines, and sexual function in bipolar patients. Am. J. Psychiatry, 149, 801–805, 1992 Ghadirian AM, Chouinard G, Annable L:Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.
J Nerv Ment Dis, 170, 453-467, 1982 Giammusso B, Morgia G, Spampinato A, Motta M: La paroxetina nel trattamento della eiaculazione precoce Arch Ital Urol Androl, 69, 1, 11-13, 1997 Gil-Nagel A, López-Muñoz F, Serratosa JM, Moncada I, García-García P, Alamo C: Effect of lamotrigine on sexual function in patients with epilepsy.
Seizure, 15, 142–149, 2006 Giorgi PM : Trattamento dell’eiaculazione precoce primitiva con inibitori selettivi dei re-uptake della serotonina (SSRIs).
Riv Sessuol, 24, 3, 256-259, 2000 Girgis SM, El-Haggar S, El-Hermouzy S: A double-bind trial of clomipramine in premature ejaculation.
Andrologia, 14, 4, 364-368, 1982 Gitlin MJ:Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches.
J. Clin Psychiatry, 56, (9), 406-13, 1994 Gitlin MJ:Effects of depression and antidepressants on sexual functioning.
Bull Menninger Clin., 59, (2), 232-48, 1995 Gitlin M.:Sexual dysfunction with psychotropic drugs.
Expert Opin Pharmacother., 4, (12), 2259-69, 2003 Gitlin MJ, , Suri R, Altshuler L, Zuckerbrow-Miller J, Fairbanks L: Bupropion-Sustained Release as a Treatment for SSRI-Induced Sexual Side Effects.
Journal of Sex & Marital Therapy, 28:131–138, 2002 Goodnick PJ, Rodriguez L, Santana O:Antipsychotics: impact on prolactin levels. Exp Opin Pharm, 3, 1381–1391, 2002 Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, Jacob KJ:Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial.
Am J Psychiatry, 163, 494-499, 2006 Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM:Antidepressant-induced sexual dysfunctionAnn Pharmacother, 36, (10), 1557-89, 2002 Grootens KP, Van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes Ziprasidone versus olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophr Bull., 37, 2, 352-361, 2011 doi: 10.1093/schbul/sbp037First published online: June 19, 2009 Haberfellner EM:Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trialsPharmacopsychiatry, 40, (5), 173-82, 2007 Haddad PM, Sharma SG: Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs, 21, 911–936, 2007 Haddad PM, Wieck A:Antipsychotic-induced hyperprolactinaemia. Mechanisms, clinical features and management.
Drugs, 64, (20), 2291-2314, 2004 Haensel SM, Rowland DL, Kallan KTHK, Koos Slob A: Clomipramine and sexual function in men with premature ejaculation and controls.
J Urol, 156, 4, 1310-1315, 1996 Haensel SM, Klem TM, Hop WC, Slob AK: Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study.
J Clin Psychopharmacol, 18, 1, 72-77, 1998 Hamer S, Haddad PM:Adverse effects of antipsychotics as outcome measures.
Br J Psychiatry, 191, suppl. 50, s64-s70, 2007 Harden CL: Sexuality in men and women with epilepsy. CNS Spectr. 11, 13–18, 2006 Harden CL:Sexuality in women with epilepsy.
Epilepsy Behav, 7, suppl.2, S2-6, 2005 Harden CL:Sexual dysfunction in women with epilepsy.
Seizure, 17, 2, 131-5, 2008 Haro JM, Salvador-Carulla L:The SOHO (Schizophrenia Outpatient Health Outcome) study. Implications for the treatment of schizophreniaCNS Drugs, 20, 4, 293-301, 2006 Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, Farina EL, Frye CA:Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsyNeurology , 65, 1016-1020, 2005 Higgins A, Barker P, Begley CM:Neuroleptic medication and sexuality: the forgotten aspect of education and care.
J Psychiatr Ment Health Nurs., 12, 439-446, 2005 Hindmarch I:The behavioural toxicity of antidepressants: effects on cognition and sexual function.
Int Clin Psychopharmacol., 13, (suppl. 6), 65-8, 1998 Sexual dysfunction in depression: disease or drug-related ?Depression and anxiety, 7, 1, 21-23, 1998 Hirschfeld RM: Management of sexual side effects of antidepressant therapy.
J Clin Psychiatry , 60, (suppl. 14), 27–30, 1999 Hirschfeld RM, Vornik LA.:Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine. J Clin Psychiatry , 65,(suppl. 4), 46–52, 2004 Hummer M, Huber J:Hyperprolactinaemia and antipsychotic therapy in schizophrenia-Curr Med Res Opin., 20, (2), 189-97, 2004 Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW:Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
Am J Psychiatry, 156, 631-633, 1999 Isojärvi JI, Löfgren E, Juntunen, KS, Pakarinen AJ, Päivänsalo M, Rautakorpi I, Tuomivaara L:Effect of epilepsy and antiepileptic drugs on male reproductive health.
Neurology, 62, 247-253, 2004 Istikoglou C, Vlissides D, Michelidakis K, Michelidakis O: Quality of life: sexual dysfunction in young people with schizophrenia treated with ziprasidone. Eur Neuropsychopharm, 19, S511, 2009 Kaplan PM: The use of serotoninergic uptake inhibitors in the treatment of premature ejaculation.
J Sex Marital Ther, 20, 321- 324, 1994 Kara H, Aydin S, Agargun MY, Odabas O, Yilmz Y: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study.
J Urol, 156, 1631-1632, 1996 Kaufman KR, Stern L, Mohebati A, Olsavsky A, Hwang J:Ziprasidone-induced priapism requiring surgical treatment.
Eur Psychiatry, 21, 1 , 48-50, 2006 Kelly DL, Conley RR:A randomized double-blind 12-week study of quietapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.
Psychoneuroendocrinology, 31, 340-346, 2006 Kelly DL, Conley RR:Sexuality and schizophrenia: a review.
Schizophr Bull, 30, 4, 767-779, 2004 Kelly DL, Conley RR:Evaluating sexual function in patients with treatment-resistant schizophrenia.
Schizophr Res, 63, 195-196, 2003 Keltner NL, McAfee KM, Taylor CL:Mechanisms and tretments of SSRI-Induced Sexual DysfunctionPerspect Psychiatr Care, 38, 3, 111-116, 2002 Kennedy SH: Favorable sexual profile of agomelatine in depressed patientsEur Neuropsychopharmacol, 16, suppl. 4, S 319, 2006 Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM: Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
J Clin Psychiatry, 61, (4), 276-81, 2000 Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S: Sexual function during bupropion or paroxetine tretment of major depressive disorder.
Can J Psychiatry, 51, (4), 234-242, 2006 Kennedy SH, Guilleminault C:Antidepressant efficacy of agomelatine 25-50 mg versus venlafaxine 75 -150 mg: two randomized, double blind studies.
Eur Neuropsychopharmacol, 16, suppl. 4, S 319-320, 2006 Kennedy SH, Rizvi S, Fulton K, Rasmussen J: A Double-blind comparison of sexual functioning, antidepressant efficacy and tolerability between agomelatine and venlafaxine XR. J. Clin. Psychopharmacol., 28, 3, 329–333, 2008 Kennedy SH, Rizvi S: Sexual dysfunction, depression, and the impact of antidepressants. J. Clin. Psychopharmacol. 29, 157–164, 2009 Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L’Italien A multicentre, randomized, naturalistic, open-label study between aripripazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenia Trial of Aripripazole: (STAR) study.
Eur Psychiatry, 22, 433-443, 2007 Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–3105, 2003 Khawaja MY:Sexual dysfunction in male patients taking antipsychotics.
J Ayub Med Coll Abbottabad, 17, 3, 73-75, 2005 Kilic S, Ergin H, Baydinc YC :Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug.
International J Andrology, 28, 47-52, 2005 Kim SW, Paick JS: Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation.
Urology, 54, 3, 544-547, 1999 Kim SC, Seo KK: Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
J Urology, 159, 425-427, 1998 Kindler S, Dolberg OT, Cohen H, Hirschmann S, Kotler M: The treatment of comorbid premature ejaculation and panic disorder with fluoxetine.
Clinical Neuropharmacology, 20, 5, 466-471, 1997 Kinzl JF:Major depressive disorder, antidepressants and sexual dysfunction.
Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation, 23, 2, 134-8, 2009 Kleinberg DL, Davis JM, de Coster R, Van Baelen B, Brecher M :Prolactin levels and adverse events in patients treated with risperidone.
J Clin Psychoharmacol, 19, 1, 57-61, 1999 Knegtering H:Antipsychotic treatment and sexual functioning, the role of prolactin. Ph.D. Thesis, 2003.
University Medical Center Groningen, University of Groningen, The Netherlands, Department of Psychiatry. Knegtering H, Blijd C, Boks MPM :Sexual dysfunction and prolactin levels in patients using classical antipsychotics, risperidone or olanzapine.
Schizophr. Res, 36, (1-3), 355-356, 1999 Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D:A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning.
J Sex Mar Ther., 32, 315-326, 2006 Knegtering H, Bruggeman, R: What are the effects of antipsychotics on sexual functioning ? Primary Psychiatry, 14, 2, 51–56, 2007 Knegtering H., Castelein S:Antipsychotics and sexual functioning questionnaire (ASFQ). In: Knegtering, H. (Ed.): Antipsychotic Treatment and Sexual Functioning, the Role of Prolactin.
University Medical Center Groningen, The Netherlands, Department of Psychiatry, 2003 Knegtering R, Castelein S, Bous H, Van Der Linde J, Bruggeman R, Kliter H, van A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.
J Clin Psychopharmacol, 24, 1, 56-61, 2004 Knegtering H, Van den Bosch R, Castelein S, Bruggeman R, Sytema S, Van Os J:Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology, 33, 711–717, 2008 Knegtering H, Van den Moolen AEGM, Castelein S, Kluiter H, van den Bosch RJ :What are the effects of antipsychotics on sexual dysfunction and endocrine functioning ?Psychoneuroendocrinology, 28, suppl.2, 109-123, 2003 Kotin J, Wilbert DE, Verburg D, Soldinger S:Thioridazine and sexual dysfunctionAm J Psichiatry, 133, 1, 82-85, 1976 Kulik FA, Wilbu R.:Case report of paiful ejaculation as a side effect of amoxapine.
Am J Psychiatry, 139, 234-235, 1982 Labbate LA:Psychotropics and sexual dysfunction: the evidence and treatments.
Adv Psychosom Med, 29, 107-30, 2008 Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D:Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.
Eur Psychiatry, 19, 7, 415-422, 2004 Langworth S, Bodlund O, Agren S:Efficacy and tolerability of reboxetine compared with citalopram. J Clin Psychopharmacol, 26, 121-127, 2006 La Torre A.: Il trattamento psicofarmacologico dell’eiaculazione precoce: analisi della letteratura. Riv Sessuologia, 23, 4, 379-401, 1999 Impotenze sessuali indotte da psicofarmaci.
pag. 381-399, in: Rifelli G, Rifelli G: “Impotenza maschile, femminile, di coppia”.
Scione Editore, Roma, 2010 La Torre A, D’Antonio P:Impotenze organiche di natura neurologica.
Pag. 353-379, in: Rifelli G, Rifelli G: “Impotenza maschile, femminile, di coppia”.
Scione Editore, Roma, 2010 Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537–544, 1999 Lee BH, Kim YK, Park SH :Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
Prog Neuropsychopharmacol Biol Psychiatry, 30, 4, 714-717, 2006 Lee HS, Song DH, Kim CH, Choi HK: An open clinical trial of fluoxetine in the treatment of premature ejaculation.
J Clin Psychopharmacol, 16, 5, 379-382, 1996 Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 353, 12, 1209–1223, 2005 Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K:The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.
Acta Psychiatr Scand, suppl. 334, 76, 1-100, 1987 Liu-Seifert H, Kinon BJ, Tennant CJ, Sniadecki J, Volavka J:Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidoneNeuropsychiatric Disease and Treatment, 5, 47–54, 2009 Ludovico GM, Corvasce A, Pagliarulo G, Cirillo-Marucco E, Marano A, Pagliarulo Paroxetine in the treatment of premature ejaculation.
Br J Urology, 77, 881-882, 1996 Lukoff D, Gioia-Hasick D, Sullivan G, Golden JS, Nuechterlein KH:Sex education and rehabilitation with schizophrenic male outpatients. Schizophr Bull, 12, 669–677, 1986 Lydiard RB, Howell EF, Laraia MT, Ballenger JC:Sexual side effects of alprazolam. Am. J. Psychiatry, 144, 254–255, 1987 MacHale S, Phanjoo AL: SSRIs to treat sexual dysfunction.
Br J Psychiatry, 164, 6, 854, 1994 Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S, McCreadie RG:Nithsdale schizophrenia surveys 24: sexual dysfunction. Case-control study.
Br J Psychiatry, 182, 50-56, 2003 Maguire GA: Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psych, 63, (Suppl 4), 56–62, 2002 Mahmoud A, Hayhurst KP, Drake RJ, Lewis SW:Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial.
Schizophrenia Research and TreatmentVolume 2011, Article ID 596898, 6 pagesdoi:10.1155/2011/596898 Malik P:Sexual dysfunction in schizophrenia.
Curr Opin Psychiatry, 20, (2), 138-42, 2007 Malik P:Sexual dysfunction in schizophrenia.
Focus, 6, 2, 234-238, 2008 Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman AM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Yevich SJ, Davis B, Shon S:Physical health monitoring of patients with schizophrenia.
Am J Psichiatry, 161, 8, 1334-1349, 2004 Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T:Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.
Schizophr Res, 61, (2-3), 123-136, 2003 Margolese HC, Assalian P.:Sexual side effects of antidepressants: a review.
J Sex Marital Ther, 22, (3), 209-17, 1996 Mathew RJ, Weinman ML: Sexual dysfunctions in depression. Arch. Sex. Behav. 11, 323–328, 1982 McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R: The Arizona Sexual Experience Scale (ASEX): reliability and validity. J. Sex Marital Ther. 26, 25–40, 2000 McMahon CG: Treatment of premature ejaculation with sertraline hydrochloride.
Int J Impot Research, 10, 181-184, 1998 McMahon CG, Touma K: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studiesJ Urol, 161, 6, 1826-1830, 1999 Mendels J, Camera A, Sikes C: Sertraline treatment for premature ejaculation.
J Clin Psychopharmacol, 15, 3411-346, 1995 Menon A, Williams RH, Watson S:Increased libido associated with quietiapine.
J Psychopharmacol, 20, 1, 125-7, 2006 Michael A, Owen A: Venlafaxine-induced increased libido and spontaneous erections.
Br J Psychiatry, 170, 193, 1997 Micheal A, Ramana R:Nefazodone-induced spontaneous ejaculation.
Br J Psychiatry, 169, (5), 672-673, 1996 Michelson D, Bancroft J, Targum S, Kim Y, Tepner R:Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.
Am J Psychiatry, 157, 2, 239-243, 2000 Mir A, Shivakumar K,Williamson RJ, McAllister V, O’Keane V, Aitchison KJ:Change in sexual dysfunction with aripiprazole: a switching or add-on study.
J Psychopharmacol, 22, 244–253, 2008 Modell JG, Katholi CR, Modell JD, DePalma RL:Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
Clin Pharmacol Ther., 61, (4), 476-87, 1997 Monteiro WO, Norsirvani HF, Marks IM, Lelliot PT: Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial.
Br J Psychiatry, 151, 107-112, 1987 Montejo AI, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Daniel E, de Dios A, de la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E: Disfunciòn sexual secundaria a ISRS. Anàlisis comparativo en 308 pacientes (Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients).
Actas Luso Esp Neurol Psiquiatr Cienc Afines, 24, 6, 311-321, 1996 Montejo AL:Prolactin awareness: an essential consideration for physical health in schizophrenia.
Eur Neuropsychopharmacol., 18, suppl 2, S 108-14, 2008 Montejo AL, Campos MC, Fombellida C, Franco M, Garcia Mellado J, Perez-Urnaiz A, Olivares JM, Ortega MA, Prieto N, Riesgo Y, Barber I: Prospective, multicenter, open-label, observational study of sexual function in patients beginning aripiprazole treatment. Eur Psychiatry, 23, S133–S134, 2008 Montejo AL, García M, Espada M, Rico-Villademoros F, Llorca G, Izquierdo JA: Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions. Actas Esp. Psiquiatr., 28, 141–150, 2000 Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F:Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry, 62, (suppl. 3),10–21, 2001 Montejo AL, Majadas S, Rico-Villademoros F, Llorca G, de la Gandara J, Franco M, Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med, 7, 3404–3413, 2010 Montejo AL, Prieto N, Terleira A, Matias J, Alonso S, Paniagua G, Naval S, Parra Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.
J. Psychopharmacol., 24, 1, 111-120, 2010 Montejo AL, Rico-Villademoros F: Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther, 34, 227–239, 2008 Montejo AL, Rico-Villademoros F:Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
Spanish Working Group for the Study of Psychotropic-Related Sexual DysfunctionJ Clin Psychopharmacol, 28, 5, 568-70, 2008 Montejo-Gonzales AI, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, de Dios A, de la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E: SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
J Sex Marital Ther, 23, 3, 176-194, 1997 Montejo González AL, Rico-Villademoros F, Tafalla M, Majadas S :A 6-month prospective observational study on the effects of quetiapina on sexual functioning.
J Clin Psychopharmacol, 25, 6, 533-538, 2005 Montgomery S.A., Baldwin D.S., Riley A.: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunctionJ Affect Disord, 69, (1-3), 119-140, 2002 Mullen B, Brar JS, Vagnucci AH, Ganguli R:Frequency of sexual dysfunction in patients with schizophrenia on haloperidol, clozapine, or risperidone.
Schizophr Res, 48, 155-158, 2001 Murat Basar M, Atan A, Yildiz M, Baykam M, Aydoganli L: Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation.
Arch Esp Urol, 52, 9, 1008-1011, 1999 Murthy S, Wylie K:Sexual problems in patients on antipsychotic medication.
Sexual Relationship Ther., 22, 1 97-107, 2007 Nagaraj AK, Pai NB, Rao S: A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine. Indian J Psychiatry, 51, 265–271 2009 Nakonezny PA, Byerly MJ, Rush AJ:The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
J Sex Marital Ther., 33, 203-216, 2007 NIH: NIH Consensus Development Panel on Impotence. J A M A, 270, (1). 83-90, 1993 Nelson JC, Pritchett YL, Martynorv O, Mallinckrodt CH, Detke MJ:The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trialsJ Clin Psychiatry, 8, 212-219, 2006 Nnaji RN, Friedman T:Sexual dysfunction and schizophrenia: psychiatrist’ attitudes and training needs.
Psychiatric Bull, 32, 208-210, 2008 Norden MJ: Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors.
Depression, 12, 109-112, 1994 Noyes R, Garvey MJ, Cook BL, Samuelson L:Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
J Clin Psychiatry, 50, 163-169, 1989 Nunes LVA, Dieckmann LHJ, Lacaz FS, Bressan R, Matsuo T, Mari JDJ:The accuracy of the Arizona Sexual Experience Scale (ASEX) to identify sexual dysfunction in patients of the schizophrenia spectrum.
Revista de Psiquiatria Clínica, 36, 5, 182-9, 2009 Olfson M, Uttaro T, Carson WH, Tafesse E :Male sexual dysfunction and quality of life in schizophrenia.
J Clin Psychiatry, 66, 3, 331-338, 2005 Orazzo C, Bortolotti F, Monteleone P:Gli psicofarmaci e la funzionalità sessuale nella pratica clinica.
Organizzazione Mondiale della Sanità (World Health Organization): ICD-10Masson, 1996 Penovich PE: The effects of epilepsy and its treatment on sexual and reproductive function. Epilepsia, 41, (suppl. 2), S53–S61, 2000 Perez V, Canas F, Tafalla M:A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. Int Clin Psychopharmacol, 23, 138–149, 2008 Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ:Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed PatientsNeuropsychopharmacology, 34, 1819–1828, 2009 Peuskens J: Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry, 166, 712–726, 1995 Peuskens J, Sienaert P, De Hert M:Sexual dysfunction: the unspoken side effect of antipsychotics Eur Psychiatry, 13, (suppl 1), 23s-30s, 1998 Philipp M, Kohnen R, Benkert O:A comparison study og moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction.
Int Clin Psychopharmacol., 7, (3-4), 149-53, 1993 Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D:Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study.
Am J Psychiatry, 154, 1757-1759, 1997 Pollack MH, Reiter S, Hammerness P: Genitourinary and sexual adverse effects of psychotropic medication. Int. J. Psychiatry Med., 22, 305–327, 1992 Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR:Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Arch Gen Psychiatry, 60, 7, 681-690, 2003 Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabisigh R, Miloslavsky M, Kell S:Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
Lancet, 368 (9539), 929-937, 2006 Reeves RR, Kimble R:Prolonged erections associated with ziprasidone treatment: a case report.
J Clin Psychiatry, 64, 1, 97-8, 2003 Rettenbacher MA, Hofer A, Ebenbichler C, Baumgartner S, Edlinger M, Engl J, Kaser S, Kemmler G, Malik P, Tschoner A, Fleischhacker WW:Prolactin Levels and Sexual Adverse Effects in Patients With Schizophrenia During Antipsychotic Treatment.
J Clin Psychopharmacology, 30, 6, 711-715, 2010doi: 10.1097/JCP.0b013e3181faf0e3 Rosen RC, Lane RM, Menza M:Effects of SSRIs on sexual function: a critical review.
J Clin Psychopharmacol., 19, (1), 67-85, 1999 Rosenberg KP, Bleiberg KL, Koscis J, Gross C:A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance.
J Sex Marital Ther., 29, (4), 289-296, 2003 Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. Int Clin Psychopharmacol, 23, 4, 216-22, 2008 Rosso C., Furlan P. M.:La terapia psicosessuologica e psicofarmacologica dell'eiaculazione precoce.
Riv Sessuol, 22, 3, 267-279, 1998 Rothschild AJ: Sexual side effects of antidepressants.
J Clin Psychiatry, 61, (suppl 11), 28-36, 2000 Rowland DL, Tai WL, Brummett K, Slob AK:Predicting responsiveness to the tretment of rapid ejaculation with 25 mg clomipramine as needed.
Int J Impot Res, 16, 354-357, 2004 Rudkin L, Taylor M, Hawton K:Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database of Systematic Reviews, Issue 4, Art. No.: CD003382, 2004. DOI: 10.1002/14651858.CD003382.pub2.
Safarinejad MR:Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double blind, placebo-controlled, fixed-dose, randomized study.
Clin Neuropharmacol, 29, (5), 243-52, 2006 Saferinejad MR:Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study.
J Clin Psychopharmacol., 27, 5, 444-450, 2006 Safarinejad MR:The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized studyB J U International, 11 febb. 2010doi:10.1111/j.1464-410X.2009.09154.x Safarinejad MR:
Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in
menstruating women: a double-blind, placebo-controlled and randomized study
J Psychopharmacol, 25, 3, 370-378, 2011
Saferinejad MR, Hosseini SY:Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study.
Int J Impot Res, 18, (2), 164-169, 2006 Safarinejad MR, Hosseini SY, Asgari MA, Dadkhah F, Taghva A: A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating womenB J U International, 11 febb. 2010doi:10.1111/j.1464-410X.2010.09208.x Saiz-Ruiz J, Montes JM, Ibanez A, Diaz M, Vicente F, Pelegrin C, Vinas R, Arias F, Carrasco JL, Ferrando L:Assessment of sexual functioning in depressed patients treted with mirtazepine: a naturalistic 6-month study.
Hum Psychopharmacol., 20, 6, 435-440, 2005 Schweitzer I, Maguire K, Ng C: Sexual side-effects of contemporary antidepressants: reviewAustralian and New Zealand Journal of Psychiatry 2009; 43:795-808 Segraves RT: Effects of psychotropics drugs on human erection and ejaculation.
Arch Gen Psychiatry, 46, 275-284, 1989 Segraves RT.
Antidepressant-induced sexual dysfunction.
J Clin Psychiatry , 59, (suppl. 4), 48–54, 1998 Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A:Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in non depressed women.
J of Sex and Marithal Therapy, 27, 303-316, 2001 Segraves RT, Saran A, Segraves K, Maguire E: Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study.
J Sex Marital Ther, 19, 3, 198-200, 1993 Serretti A, Chiesa A :Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
J Clin Psychoparmacol, 29, 3, 259-66, 2009 Serretti A, Chiesa A :Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento.
Giorn Ital Psicopatol, 16, 104- 113, 2010 Serretti A, Chiesa A :A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics.
International Clinical Psychopharmacology, POST AUTHOR CORRECTIONS, 28 December 2010DOI: 10.1097/YIC.0b013e328341e434 Serretti A, Chiesa A :Sexual Side Effects of Pharmacological Treatment of Psychiatric Diseases.
Nature, 89, 1, 142- 147, 2011 Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M:Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
B J U Int, 102, (7), 824-8, 2008 Smith DM, Levitte SS:Association of fluoxetine and return of sexual potency in three elderly man.
J Clin Psychiatry, 54, 317-319, 1999 Smith S, Wheeler MJ, Murray R, O’Keane V:The effects of antipsychotic-induced hyperprolactinaemia on the hypotalamic-pituitary-gonadal axis.
J Clin Psychopharmacol, 22, 109-114, 2002 Smith SM:The impact of hyperprolactinaemia on sexual function in patients with psychosis.
J Psychopharmacol, 22, (2 suppl.), 63-9, 2008 Smith SM, O’Keane V, Murray R:Sexual dysfunction in patients taking conventional antipsychotic medication.
Br J Psychiatry, 181, 49-55, 2002 Stahl SM: Stahl’s Essential Psychopharmachology: Neuroscientific Basis and Practical Applications (third edition).
Cambridge University Press, 2008 Sthal SM:The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response.
J Clin Psychiatry, 62, 2, 80-81, 2001 Sthal SM:The psychopharmacology of sex, Part 2: Effects of drugs on the 3 phases of the human sexual response.
J Clin Psychiatry, 62, 3, 147-148, 2001 St. Lawrence JS, Madakasira S: Evaluation and treatment of premature ejaculation: a critical review.
Comprehensive Psychiatry, 22, 1, 77- 97, 1992 Stimmel GL, Gutierrez MA:Sexual dysfunction and psychotropic medicationsCNS Spectr., 11, (8 Suppl 9), 24-30, 2006 Strassberg DS, De Gouveia Brazao CA, Rowland DL, Tan P, Slob K :Clomipramine in the tratment of rapid (premature) ejaculation.
J Sex Marital Ther, 25, 89-101, 1999 Strous RD, Kupchik M, Roitman S, Schwartz S, Gonen N, Mester R, Weizman A, Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study.
Hum Psychopharmacol, 21, 4, 235-243, 2006 Sullivan G :Increased libido in three man treated with trazodone.
J Clin Psychiatry, 49, 202-203, 1988 Talbot JA, Sheldrick R, Caswell H, Duncan S:
Sexual function in men with epilepsy: how important is testosterone?
Neurology. 70, 1346-1352, 2008
Taylor MJStrategies for managing antidepressant-induced sexual dysfunction: a reviewCurr Psychiatry Rep., 8, (6), 431-6, 2006 Taylor MJ, Rudkin L, Hawton KStrategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials.
J Affect Disord, 88 , (3), 241-54, 2005 Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston Ja: A double-blind comparison between bupropion XL and venlafaxine XR. Sexual functioning, antidepressant efficacy and tolerabilityJ Clin Psychoparmacol., 26, (5), 482-488, 2006 Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S, Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry, 66: 974-981, 2005 Treuer T, Anders M, Bitter I, Dobre G, Pecenak J, Dyachkova Y, Harrison G, Effectiveness and tolerability of schizophrenia tretment in central and eastern Europe: results after 1 year from a prospective, observational study (IC- SOHO).
Int J Psychiatr Clin Pract, 10, 2, 78-90, 2006 Uçok A, Incensu C, Aker T, Ercoç S:Sexual dysfunction in patients with schizophrenia on antipsychotic medication.
Eur Psychiatry, 22, 328-333, 2007 Van Bruggen M, Van Amelsvoort T,Wouters L, Dingemans P, de Haan L, Linszen Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone. Psychoneuroendocrinology, 34, 989–995, 2009 Antidepressant Side Effects in Depression Patients Treated in a Naturalistic Setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Can J Psychiatry, 47, (2), 174-80, 2002 Versiani M, Moreno R, Ramakers-van Moorsel CJA, Schutte AJ:Comparison of the effects of mirtazepine and fluoxetine in severely depressed patients. CNS Drugs, 19, 137-146, 2005 Villeneuve J, Demers M, Almeras N, Proulx I, Labelle A, Bourget D, Mottard J, Roy Advantages of quetiapine on sexual dysfunctions: a switch study. Schizophr Bull, 31, 572, 2005 Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP, Citrome L, McEvoy Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
J Clin Psychiatry, 65, 1, 57-61, 2004 Wade A, Crawford GM, Angus M, Wilson R, Hamilton L: A randomised, double-blind, 24-weekstudy comparing the efficacy and tolerability of mirtazepine and paroxetine in depressed patients in primary care. Int Clin Psychopharmacol., 18, 133-141, 2003 Waldinger MD:Lifelong premature ejaculation: from authorithy-based to evidence-based medicine.
B J U Int, 93, 201-207, 2004 Waldinger MD, Olivier B :Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations.
Int Clin Psychoparmacol., 13, (Suppl 6), S27-33, 1998 Waldinger MD, Hengeveld MW, Zwinderman AH: Paroxetine treatment of premature ejaculation: a double-bind, randomized, placebo-controlled study.
Am J Psychiatry, 151, 1377-1379, 1994 Waldinger MD, Hengenveld MW, Zwinderman AH: Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-bind, randomized, dose-response study.
Br J Urol, 79, 592-595, 1997 Waldinger MD, Hengeveld MW, Zwinderman AH, Oliver B: Effect of SSRI antidepressant on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline.
J Clin Psychopharmacol, 18, 4, 274-281, 1998 Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline and nafazodone.
J Clin Psychopharmacol, 21, (3), 293-297, 2001 Waldinger MD, Zwindermann AH, Olivier B:Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine.
J Clin Psychopharmacol, 23, 467-70, 2003 Waldinger MD, Zwindermann AH, Olivier B:On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.
Eur. Urol, 46, (4), 510-6, 2004 Waldinger MD, Zwindermann AH, Schweitzer DH, Olivier B:Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis.
Int J Impot Res, 16, (4), 369-381, 2004 Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG:Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
J Clin Psychiatry, 54, (12), 459-65, 1993 Warner MD, Peadbody CA, Whiteford HA, Hollister LE:Trazodone and priapism.
J Clin Psychiatry, 48, 244-245, 1987 Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H:Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study. CNS Spectr, 14, 299–313, 2009 Werneke U, Northey S, Bhugra D:Antidepressant and sexual dysfunctionActa Psychiatr Scandinav, 114, 6, 384-397, 2006 Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A, Gastpar M, Huber TJ, Maier W, Murafi A, Rothermund M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Kühn K-U:Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry, 40, 4, 140–145, 2007 Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung W-P, Klingmüller D, Lemke MR, Maier W, Schubert M, Str ter B, Kühn K-U: Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone. J Sex Med., 5, 12, 2816-26, 2008 Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to Wieck A, Haddad M:Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review.
Br J Psychiatry, 182, 199-204, 2003 Williams VSL, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM:Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 european countries: a cross-sectional patient survey.
J Clin Psychiatry, 67, 204-210, 2006 Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC:Sexual side effects of novel antipsychotic medications.
Schizophr Res, 56, 25-30, 2002 Wise TN: Sertraline as a treatment for premature ejaculation.
J Clin Psychiatry, 55, 417, 1994 Yeragani VK, Gershon S:Priapism related to phenalzine therapy.
N Eng J Med., 317, (2), 117-118, 1987 Yilmaz U, Tatlisen A, Turan H, Arman F, Ekmekcioglu O: The effects of fluoxetine on several neurophysiological variables in patients wirth premature ejaculationJ Urol, 161, 1, 107-111, 1999 Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, Barnes TRE:Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.
Int Clin Psychopharmacol, 22, 238–243, 2007 Zahariou A, Papaioannou P, Karagiannis G:The efficacy of duloxetine in the treatment of premature ejaculationInternational Urology and Nephrology, 39, 115-118, 2007 Zajecka J:Strategies for the treatment of antidepressant-related sexual dysfunction.
J Clin Psychiatry, 62, suppl. 3, 35-43, 2001 Zajecka J, Mitchell S, Fawcett J :Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
Psychopharmacol Bull., 33, 755-760, 1997 The impact of mental illness on sexual dysfunction.
Balon R (ed): Sexual Dysfunction. The Brain-Body Connection.
Adv Psychosom Med., 29, 89-106, 2008 Zourková A, Cesková E, Hadasová E, Ravcuková B:Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity. J Sex Marital Ther, 33, 4, 343-55, 2007 Zourková A, Hadasová E:Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment. J Sex Marital Ther., 28, 5, 451-61, 2002


Patienteninformation herzkatheteruntersuchung

In Kooperation mit: Dr. Matthias Bohnsack Invasive Kardiologie am Klinikum Elmshorn Praxis: Friedenstr. 4, 25335 Elmshorn, Tel: 04121-485757 Patienteninformation Herzkatheteruntersuchung Sehr geehrte Patientin, sehr geehrter Patient, dieses Merkblatt soll Ihnen in Ergänzung zu dem Ihnen ebenfalls vorliegenden Aufklärungsbogen die Herzkatheteruntersuchung näherbringen,


Cannabis et Trouble Déficit de l’Attention (TDA) David Bearman, M.D., Californie (USA) Traduction autorisée par l’auteur Les symptômes principaux des types les plus connus du TDAH (Trouble Déficit de l’Attention / Hyperactivité) sont (1) suractivité motrice, (2) inattention et (3) impulsivité (American Psychiatric Associat

© 2010-2017 Pharmacy Pills Pdf